Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Cellectar Biosciences, Inc. (CLRB)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15
   10-K10-K10-K10-K10-K10-K10-K10-K
Revenues  0.00.00.00.00.00.00.00.0
Cost of goods sold  0.00.00.00.00.00.00.00.2
Gross profit  0.00.00.00.00.00.00.0-0.2
            Gross margin          
Selling, general and administrative   [+]9.66.55.15.24.84.14.73.4
Research and development  19.217.610.19.06.89.54.85.2
EBITDA   [+]-28.7-24.0 -14.0-11.6-12.1-9.1-8.4
            EBITDA margin          
Depreciation and amortization  0.10.1 0.10.11.50.40.4
EBIT   [+]-28.8-24.1-15.3-14.2-11.7-13.6-9.4-8.8
            EBIT margin          
Non-recurring items   [+]    1.7   
Interest income, net   [+]0.20.00.00.00.00.00.00.0
Other income (expense), net   [+] 0.00.20.00.10.03.33.3
Pre-tax income  -28.7-24.1-15.1-14.1-13.2-13.6-6.2-5.5
Income taxes  -0.10.00.00.00.00.00.00.0
            Tax rate  0.2%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income  -28.6-24.1-15.1-14.1-15.5-15.0-9.4-5.5
            Net margin          
   
Basic EPS   [+]($4.05)($4.35)($0.76)($1.84)($5.23)($10.70)($2.14)($7.03)
Diluted EPS   [+]($4.05)($4.35)($0.76)($1.84)($5.23)($10.70)($2.14)($7.03)
   
Shares outstanding (basic)   [+]7.15.619.87.73.01.44.40.8
Shares outstanding (diluted)   [+]7.15.619.87.73.01.44.40.8
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy